FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
FDA's newly appointed Chief Scientific Officer Frank Torti will focus on collaborations with industry and academia in order to boost the agency's scientific expertise and augment scarce resources, he said at a May 30 Science Board Meeting
You may also be interested in...
Frank Torti’s Next 100 Days: Active, Not Just Acting FDA Commissioner
Frank Torti might not be in charge of FDA for very long, but he seems determined to make his time count
Torti's Next Hundred Days: Active, Not Just Acting FDA Commissoner
FDA's Chief Scientist will continue to push for outside academic collaborations during his "short time" atop the agency; fall letter on follow-on biologics could draw closer reading.
FDA’s Torti Tapped As Acting Commissioner; Interim Heads Also Named For HHS, CMS
Chief scientist Frank Torti is a relative newcomer to FDA, having joined less than a year ago from Wake Forest University. Since then, he has headed the agency’s successful fellowship program.